A262 15 mg A262 15 mg (Lansoprazole Delayed-Release 15 mg)

Pill with imprint A262 15 mg A262 15 mg is Green & White, Capsule-shape and has been identified as Lansoprazole Delayed-Release 15 mg. It is supplied by Xiromed LLC.

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A262 15 mg A262 15 mg

Lansoprazole Delayed-Release

Imprint

A262 15 mg A262 15 mg

Strength

15 mg

Color

Green & White

Size

16.00 mm

Shape

Capsule-shape

Availability

Rx and/or OTC

Drug Class

Proton pump inhibitors

Pregnancy Category

B - No proven risk in humans

CSA Schedule

Not a controlled drug

Labeler / Supplier

Xiromed LLC

National Drug Code (NDC)

70700-0262

Inactive Ingredients

methacrylic acid - ethyl acrylate copolymer (1:1) type a, hypromelloses, magnesium carbonate, mannitol, polysorbate 20, polyethylene glycol, sodium lauryl sulfate, sodium starch glycolate type A potato, sucrose, magnesium silicate, titanium dioxide, FD&C Blue No. 2, gelatin, ferric oxide yellow, ferrosoferric oxide, propylene glycol, butyl alcohol, isopropyl alcohol, shellac

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer